Drug Profile
Research programme: T 817MA companion diagnostic - FUJIFILM Toyama Chemical/Kyoto University
Latest Information Update: 29 Oct 2018
Price :
$50
*
At a glance
- Originator Toyama Chemical
- Developer Kyoto University; Toyama Chemical
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Alzheimer's-disease(Diagnosis) in Japan
- 09 Jun 2014 Early research in Alzheimer's disease (diagnosis) in Japan (unspecified route)